GLP-1 medications are generally prescribed for adults with obesity (BMI 30) or those who are overweight (BMI 27) with related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol
Improvements in HbA1C were observed as early as four weeks and were accompanied by similar reductions in fasting serum glucose
Vaccine administration guidelines: subcutaneous injection technique
It is also being studied for its potential to slow the progression of neurodegenerative diseases like Alzheimer's
Semaglutide deep-dive Semaglutide is sold under three brand names, all manufactured by Novo Nordisk: Ozempic -- weekly injection, FDA-approved for type 2 diabetes (doses 0.25 mg, 0.5 mg, 1 mg, 2 mg) Wegovy -- weekly injection, FDA-approved for chronic weight management in 2021 (doses up to 2.4 mg) [3] Rybelsus -- daily oral tablet, approved for type 2 diabetes For weight loss specifically, Wegovy is the on-label choice